SGLT2 inhibitors vs placebo
Death (all causes) · people with diabetes and CKD
1 finding from 1 review · compare the 2 reviews
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease 2018 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 2933 participantsVery low